<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Red blood cell filtration, platelet aggregation, serum <z:chebi fb="0" ids="17855">triglyceride</z:chebi> and cholesterol levels were investigated in 15 patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> cerebrovascular disease, 10 of whom treated with Suloctidil and 5 with pentoxifylline </plain></SENT>
<SENT sid="1" pm="."><plain>The treatment was carried out in 90 days </plain></SENT>
<SENT sid="2" pm="."><plain>Both pentoxifylline and Suloctidil produced a significant improvement of erythrocyte deformability and a decrease of platelet aggregation </plain></SENT>
</text></document>